Lance Armstrong is just the beginning—get ready for plenty more doping confessions to come, writes Jonathan Mahler in Friday’s New York Post. The news that a stage IV cancer survivor could go on to win the Tour de France shouldn’t have been a surprise to anyone—despite that journalists, teammates, and sports fans all seemed to be caught unaware by the revelation. Historically, drugs have been rampant in cycling. Many are even considered acceptable to use if a doctor prescribes them, begging the question: where does the moral line lie? Mahler points to the real reason steroids have become so popular—“because we value winning above all else, and we pay winners accordingly.”
